B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

CLK1

MOLECULAR TARGET

CDC like kinase 1

UniProt: P49759NCBI Gene: 119515 compounds

CLK1 (CDC like kinase 1) is targeted by 15 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CLK1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Harmine Alkaloid isolated from seeds of PEGANUM HARMALA; ZYGOPHYLLACEAE. It is identical to banisterine, or telepathine, from Banisteria caapi and is2.4811
2Quercetin1.102
3Apigenin 5,7,4'-trihydroxy-flavone,0.691
4chrysin0.691
5egcg0.691
6fisetin0.691
7Genistein0.691
8Kaempferols0.691
9Luteolin 5,7,3',4'-tetrahydroxy-flavone,0.691
10myricetin-3-O-galactopyranoside [Supplementary Concept]0.691
11Emodin Purgative anthraquinone found in several plants, especially RHAMNUS PURSHIANA. It was formerly used as0.691
12hydroxyfasudil [Supplementary Concept]0.691
13pictilisib0.691
14Sorafenib0.691
15sp6001250.691

About CLK1 as a Drug Target

CLK1 (CDC like kinase 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 15 compounds with documented CLK1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CLK1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.